Cullen Capital Management, LLC Bristol Myers Squibb CO Transaction History

Cullen Capital Management, LLC

$9.2 Billion
Q3 2024

A detailed history of Cullen Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cullen Capital Management, LLC holds 1,311,003 shares of BMY stock, worth $75.7 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

1,311,003

Previous 1,486,869 11.83%

Holding current value

$75.7 Million

Previous $61.7 Million 9.87%

% of portfolio

0.74%

Previous 0.73%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $6.97 Million - $9.1 Million	-175,866 Reduced 11.83%	1,311,003 $67.8 Million
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $8.87 Million - $11.7 Million	220,358 Added 17.4%	1,486,869 $61.7 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $6.45 Million - $7.31 Million	134,460 Added 11.88%	1,266,511 $68.7 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $3.92 Million - $4.67 Million	80,760 Added 7.68%	1,132,051 $58.1 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $103,333 - $115,543	1,785 Added 0.17%	1,051,291 $61 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $6.71 Million - $7.45 Million	105,310 Added 11.15%	1,049,506 $67.1 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $19.2 Million - $21.8 Million	292,065 Added 44.79%	944,196 $65.4 Million
Q4 2022 Feb 16, 2023	SELL	$68.48 - $81.09 $11.5 Million - $13.6 Million	-168,213 Reduced 20.51%	652,131 $46.9 Million
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $6,257 - $3.7 Million	48,133 Added 6.23%	820,344 $58.3 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $6.81 Million - $7.5 Million	93,820 Added 13.83%	772,211 $59.5 Million
Q1 2022 May 03, 2022	BUY	$61.48 - $73.72 $3.95 Million - $4.74 Million	64,311 Added 10.47%	678,391 $49.5 Million
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $3.47 Million - $4.05 Million	64,717 Added 11.78%	614,080 $38.3 Million
Q3 2021 Nov 05, 2021	BUY	$59.17 - $69.31 $1.66 Million - $1.94 Million	28,034 Added 5.38%	549,363 $32.5 Million
Q2 2021 Aug 04, 2021	BUY	$61.91 - $67.42 $2.37 Million - $2.58 Million	38,306 Added 7.93%	521,329 $34.8 Million
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $23.5 Million - $26.5 Million	396,688 Added 459.48%	483,023 $30.5 Million
Q4 2020 Jan 26, 2021	BUY	$57.74 - $65.43 $4.15 Million - $4.71 Million	71,915 Added 498.72%	86,335 $5.36 Million
Q2 2020 Jul 31, 2020	SELL	$54.82 - $64.09 $209,138 - $244,503	-3,815 Reduced 20.92%	14,420 $848,000
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $4.67 Million - $6.78 Million	-100,580 Reduced 84.65%	18,235 $1.02 Million
Q1 2020 May 05, 2020	BUY	$46.4 - $67.43 $4.67 Million - $6.78 Million	100,580 Added 551.58%	118,815 $6.62 Million
Q4 2019 Jan 31, 2020	SELL	$49.21 - $64.19 $299,934 - $391,238	-6,095 Reduced 25.05%	18,235 $1.17 Million
Q3 2019 Nov 15, 2019	BUY	$42.77 - $50.71 $1.04 Million - $1.23 Million	24,330 New	24,330 $1.23 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cullen Capital Management, LLC with notifications on news.

Account

Cullen Capital Management, LLC Bristol Myers Squibb CO Transaction History